Canterbury DHB

Context

August 2022

Antimicrobial Guidelines

Antimicrobial Guidelines

 

Revised wording of guideline review process.

Prescribing Guidelines

Prescribing in Pregnancy

 

Revised. Medicines that are unavailable or being discontinued (rantidine, cilazapril) and links to bulletins that are no longer available have been removed.

Prescribing in Breastfeeding

 

Revised. Advice to monitor INR in breastfed infants due to maternal warfarin use has been removed.

Pharmacogenetics

 

Revised. Hepatitis C treatment was removed as an example of a treatment that is guided by genotype locally. Proportions of poor metabolisers of CYP2D6, CYP2C9 and CYP2C19 plus ultra-rapid metabolisers of CYP2D6 in populations were updated.

Information about this Canterbury DHB document (1046841):

Document Owner:

Not assigned (see Who's Who)

Last Updated:

August 2022

Next Review Due:

N/A

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document.

Topic Code: 1046841